Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Membrane potential drives the exit from pluripotency and cell fate commitment via calcium and mTOR. | Nat Commun | 2022 | 36335122 | PubTator, text mining | PubMed |
| The balance between NANOG and SOX17 mediated by TET proteins regulates specification of human primordial germ cell fate. | Cell Biosci | 2022 | 36333732 | PubTator, text mining | PubMed |
| Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene. | Stem Cell Res | 2022 | 36332467 | PubTator, text mining | PubMed |
| Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis. | Cancer Inform | 2022 | 36330202 | PubTator, text mining | PubMed |
| A Response to Article "Rho-Associated Protein Kinase Inhibitor and Hypoxia Synergistically Enhance the Self-Renewal, Survival Rate, and Proliferation of Human Stem Cells" [Letter]. | Stem Cells Cloning | 2022 | 36320340 | PubTator, text mining | PubMed |
| Transgenic animal models to explore and modulate the blood brain and blood retinal barriers of the CNS. | Fluids Barriers CNS | 2022 | 36320068 | PubTator, text mining | PubMed |
| Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor. | Sci Rep | 2022 | 36319719 | PubTator, text mining | PubMed |
| iPSCs derived from esophageal atresia patients reveal SOX2 dysregulation at the anterior foregut stage. | Dis Model Mech | 2022 | 36317486 | PubTator, text mining | PubMed |
| Large-Scale Production of Wholly Cellular Bioinks via the Optimization of Human Induced Pluripotent Stem Cell Aggregate Culture in Automated Bioreactors. | Adv Healthc Mater | 2022 | 36314397 | PubTator, text mining | PubMed |
| iPSC-derived mesenchymal cells that support alveolar organoid development. | Cell Rep Methods | 2022 | 36313800 | PubTator, text mining | PubMed |
| Silk scaffolding drives self-assembly of functional and mature human brain organoids. | Front Cell Dev Biol | 2022 | 36313550 | PubTator, text mining | PubMed |
| Amniotic fluid characteristics and its application in stem cell therapy: A review. | Int J Reprod Biomed | 2022 | 36313262 | PubTator, text mining | PubMed |
| Clinical and genetic determinants of the fatty liver-coagulation balance interplay in individuals with metabolic dysfunction. | JHEP Rep | 2022 | 36313186 | PubTator, text mining | PubMed |
| Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. | J Biomed Sci | 2022 | 36310172 | PubTator, text mining | PubMed |
| Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. | Cell Death Dis | 2022 | 36302755 | PubTator, text mining | PubMed |
| Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. | Pathogens | 2022 | 36297203 | PubTator, text mining | PubMed |
| The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer. | Life (Basel) | 2022 | 36295075 | PubTator, text mining | PubMed |
| Monodelphis domestica Induced Pluripotent Stem Cells Reveal Metatherian Pluripotency Architecture. | Int J Mol Sci | 2022 | 36293487 | PubTator, text mining | PubMed |
| The Beginning of Meiosis in Mammalian Female Germ Cells: A Never-Ending Story of Intrinsic and Extrinsic Factors. | Int J Mol Sci | 2022 | 36293427 | PubTator, text mining | PubMed |
| Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters? | Int J Mol Sci | 2022 | 36292996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=42